Oral Nucleos(t)ide Analog Therapy Alone for Chronic Hepatitis B Patients with Lamivudine-Resistance at Time of Liver Transplantation

被引：0
|
作者：
Fung, James Y. [1 ,2 ,3 ]
Kwan, Man [1 ]
Wong, Tiffany [1 ]
Chok, Kenneth [1 ]
Chan, Albert [1 ]
Cheung, Tan-to [1 ]
Dai, Wing-chiu [1 ]
Sharr, William [1 ]
Sin, Sui-ling [1 ]
Yuen, Man-fung [2 ,3 ]
Lai, Ching-lung [2 ,3 ]
Chan, See-ching [1 ,3 ]
Lo, Chung-mau [1 ,3 ]
机构：
[1] Univ Hong Kong, Surg, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Med, Hong Kong, Hong Kong, Peoples R China
[3] Univ Hong Kong, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China
来源：
TRANSPLANTATION | 2016年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
O-35
引用
收藏
页码：S91 / S91
页数：1
相关论文
共 50 条
  • [41] Dynamics of Serum Pregenome RNA in Chronic Hepatitis B Patients Receiving 96-Month Nucleos(t)ide Analog Therapy
    Tao, Yachao
    Wang, Menglan
    Liao, Juan
    Cheng, Xing
    He, Min
    Zhang, Dongmei
    Zhou, Taoyou
    Chen, Jie
    Chen, Enqiang
    Tang, Hong
    FRONTIERS IN MEDICINE, 2022, 9
  • [42] Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
    Lee, Teng-Yu
    Hsu, Yao-Chun
    Yu, Shi-Hang
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Wu, Chun-Ying
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 947 - +
  • [43] Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shift
    Liaw, Yun-Fan
    HEPATOLOGY INTERNATIONAL, 2019, 13 (06) : 665 - 673
  • [44] Risk Factor Analysis of HCC For Chronic Hepatitis B Patients With Nucleos(t)ide Analogues Therapy
    Yang, Liu-Qing
    Li, Xiang-yong
    Wu, Yuankai
    Chong, Yutian
    HEPATOLOGY, 2012, 56 : 360A - 360A
  • [45] Antiviral therapy with nucleos (t)ide analogues for severe chronic hepatitis B Reply
    Chen, Jun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2009, 8 (04) : 439 - 439
  • [46] Efficacy of tenofovir switch therapy for nucleos(t)ide-experienced patients with chronic hepatitis B
    Lo, A. O. -S.
    Wong, V. W. -S.
    Wong, G. L. -H.
    Tse, Y. -K.
    Chan, H. -Y.
    Chan, H. L. -Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1190 - 1199
  • [47] Nucleos(t)ide analog(s) prophylaxis after hepatitis B immunoglobulin withdrawal against hepatitis B and D recurrence after liver transplantation
    Cholongitas, E.
    Goulis, I.
    Antoniadis, N.
    Fouzas, I.
    Imvrios, G.
    Giakoustidis, D.
    Giouleme, O.
    Papanikolaou, V.
    Akriviadis, E.
    Vasiliadis, T.
    TRANSPLANT INFECTIOUS DISEASE, 2016, 18 (05) : 667 - 673
  • [48] Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B
    Hadziyannis, S. J.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 35 (12) : 1482 - 1482
  • [49] Durability after discontinuation of nucleos(t)ide therapy in hepatitis e antigen negative chronic hepatitis B patients
    Cho, Sung Won
    Kim, Soon Sun
    Lee, Dami
    Cho, Jin Hee
    Kim, Kee Bum
    Cheong, Jae Youn
    Cho, Sung Won
    HEPATOLOGY, 2012, 56 : 356A - 356A
  • [50] Adefovir alone or combination with lamivudine in patients with lamivudine-resistance chronic HBeAg-negative hepatitis B. A non randomized multicenter controlled study
    Manolakopoulos, S
    Bethanis, S
    Koutsounas, S
    Goulis, J
    Saveriadis, A
    Xristias, E
    Christidou, A
    Pavlidis, C
    Toubanakis, C
    Vlachogiannakos, J
    Triantos, C
    Avgerinos, A
    Tzourmakliotis, D
    HEPATOLOGY, 2005, 42 (04) : 592A - 593A
12345